Decreased Urgency Among Liver Transplantation Candidates With Hepatocellular Carcinoma in the United States
Allison J. Kwong, T. Tara Ghaziani, Neil Mehta – 21 November 2021
Utilizing Macrosteatotic Allografts for Nonalcoholic Steatohepatitis Recipients
Aleah L. Brubaker, Rohit Loomba – 21 November 2021
A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High‐Risk Primary Sclerosing Cholangitis
Emmanuel A. Selvaraj, Ahmed Ba‐Ssalamah, Sarah Poetter‐Lang, Gerard R. Ridgway, J. Michael Brady, Jane Collier, Emma L. Culver, Adam Bailey, Michael Pavlides – 20 November 2021 – Magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRI‐MRCP) in primary sclerosing cholangitis (PSC) is currently based on qualitative assessment and has high interobserver variability. We investigated the utility and performance of quantitative metrics derived from a three‐dimensional biliary analysis tool in adult patients with PSC.
Joining the Fight: Enhancing Alcohol Treatment Education in Hepatology
Adam C. Winters, Elizabeth S. Aby, Oren K. Fix, Margarita German, Lamia Y.K. Haque, Gene Y. Im – 19 November 2021
Letter to the editor: New kid in the playground: HBcrAg and risk of HCC
Jer‐Wei Wu, Tai‐Chung Tseng, Jia‐Horng Kao – 19 November 2021
Reply
Marc G. Ghany, Wendy C. King, Mauricio Lisker‐Melman, Anna S. F. Lok, Norah Terrault, Harry L. A. Janssen, Mandana Khalili, Raymond T. Chung, William M. Lee, Daryl T. Y. Lau, Gavin A. Cloherty, Richard K. Sterling – 19 November 2021
CON: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should not Undergo Liver Transplantation
Maureen Whitsett, Vivian Ortiz, Ethan M. Weinberg – 19 November 2021
Letter to the editor: The addition of C‐reactive protein and von Willebrand factor to Model for End‐Stage Liver Disease‐Sodium
Meng‐Si Luo, Guan‐Jiang Huang – 19 November 2021
Reply
David Pereyra, Mattias Mandorfer, Julie Heimbach, Patrick Starlinger – 19 November 2021